RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era

SIMPLE SUMMARY: Nowadays, most metastatic renal cell carcinoma (mRCC) patients are candidates for immunotherapy. Risk stratification is based on the IMDC model that was developed in an earlier era of vascular endothelial growth factor receptor inhibitors (VEGFRi). An updated, more accurate model is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagie, Shira, Sarfaty, Michal, Levartovsky, Meital, Gantz Sorotsky, Hadas, Berger, Raanan, Percik, Ruth, Gadot, Moran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265130/
https://www.ncbi.nlm.nih.gov/pubmed/35804899
http://dx.doi.org/10.3390/cancers14133127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265130/
https://www.ncbi.nlm.nih.gov/pubmed/35804899
http://dx.doi.org/10.3390/cancers14133127

Ejemplares similares